Aminoglycosides are currently considered to be among the few antibiotics useful in the treatment of infections caused by Pseudomonas aeruginosa. The discrepancy between in vitro and in vivo susceptibility is a major problem in aminoglycoside therapy (6, 8) . The well-documented antagonism of aminoglycosides by divalent cations (18, 25) is one probable cause, and development of adaptive (nonmutational) resistance in vivo may also play a part. We recently showed that, in P. aeruginosa, induction of a major outer membrane protein, Hi, results in resistance to polymyxins and ethylenediaminetetraacetate (EDTA) (21). The increase in outer membrane protein Hi was accompanied by a decrease in cell envelope Mg2". Mutants which overproduce outer membrane protein Hi also show enhanced resistance to aminoglycosides (21), suggesting the involvement of an outer membrane site, which could be protected by outer membrane protein Hi, in the activity of these antibiotics. We report here that P. aeruginosa induced for outer membrane protein Hi, either as a result of adaptation to growth in low Mg2" or in mutants, has altered kinetics of aminoglycoside killing and uptake. Furthermore, we demonstrate that aminoglycosides can permeabilize outer membranes to lysozyme and a 8-lactam antibiotic by a mechanism which is extremely rapid and independent of aminoglycoside killing and energized uptake but is inhibited by Mg2". Our results suggest a mechanism of uptake across the outer membrane different from the previously characterized hydrophilic (porin-mediated) and hydrophobic pathways (22).
Induction of a major outer membrane protein, Hi, in Pseudomonas aeruginosa resulted in decreased susceptibility to gentamicin and streptomycin. Mutants which overproduce protein Hi and cells in which Hi is induced in response to growth conditions had altered kinetics of uptake and killing. It was further demonstrated that gentamicin and streptomycin interact with the outer membrane to permeabilize it to lysozyme and to increase the permeation of a chromogenic f)-lactam, nitrocefin. Experiments with inhibitors of aminoglycoside uptake showed that uptake was not required to increase permeability. Mg2e at 1 mM totally inhibited aminoclycoside-mediated outer membrane permeabilization. We propose that the uptake and killing by these aminoglycosides requires interaction with an Mg2e binding site at the outer membrane, permitting aminoglycoside uptake into the periplasm.
Aminoglycosides are currently considered to be among the few antibiotics useful in the treatment of infections caused by Pseudomonas aeruginosa. The discrepancy between in vitro and in vivo susceptibility is a major problem in aminoglycoside therapy (6, 8) . The well-documented antagonism of aminoglycosides by divalent cations (18, 25) is one probable cause, and development of adaptive (nonmutational) resistance in vivo may also play a part. We recently showed that, in P. aeruginosa, induction of a major outer membrane protein, Hi, results in resistance to polymyxins and ethylenediaminetetraacetate (EDTA) (21) . The increase in outer membrane protein Hi was accompanied by a decrease in cell envelope Mg2". Mutants which overproduce outer membrane protein Hi also show enhanced resistance to aminoglycosides (21) , suggesting the involvement of an outer membrane site, which could be protected by outer membrane protein Hi, in the activity of these antibiotics. We report here that P. aeruginosa induced for outer membrane protein Hi, either as a result of adaptation to growth in low Mg2" or in mutants, has altered kinetics of aminoglycoside killing and uptake. Furthermore, we demonstrate that aminoglycosides can permeabilize outer membranes to lysozyme and a 8-lactam antibiotic by a mechanism which is extremely rapid and independent of aminoglycoside killing and energized uptake but is inhibited by Mg2". Our results suggest a mechanism of uptake across the outer membrane different from the previously characterized hydrophilic (porin-mediated) and hydrophobic pathways (22) .
MATERIALS AND METHODS
Bacterial strains. P. aeruginosa PA01 strain H103 and its derivatives H181 and H185 were previously described (21) . Strains H181 and H185 were isolated as polymyxin-resistant mutants and were previously shown to demonstrate EDTA resistance and low-level aminoglycoside resistance (21) . The polymyxin B-resistant mutants H181 and H185 produced high levels of protein Hi in both media. In both the mutants and the induced bacteria, outer membrane protein Hi appeared to be the cellular protein present in the largest quantity.
Effects of growth conditions and outer membrane protein Hi induction on resistance to killing by aminoglycosides. We previously demonstrated (21) that the polymyxinresistant isolates H181 and H185 had miniimal inhibitory concentrations of gentamicin and streptomycin fourfold higher than the parent strain H103. It was suggested that the high levels of outer membrane protein Hi in H181 and H185 were responsible for the enhanced resistance to aminoglycosides. To confirm this, H103
and its derivatives were grown in either Mg2e-sufficient or Mg2e-deficient modified nutrient broth and subsequently resuspended and tested for aminoglycoside killing in a common assay medium ( Fig. 1 and 2 ). The parent strain H103 grown in Mg2+-sufficient medium was susceptible to a wide range of concentrations of gentamicin ( Fig. 1) . Growth of H103 in Mg2e-deficient medium, which induces outer membrane protein Hi, resulted in a marked decrease in sensitivity to killing at all gentamicin concentrations. The level of resistance achieved was similar to that seen for the polymyxin-resistant isolates H181 ( Fig. 1 ) and H185 (data not shown) grown under Mg2e-sufficient conditions. Altered killing kinetics were also observed. Strain H103 grown in Mg2+-sufficient medium showed a rapid loss of viability when exposed to gentamicin in assay medium with 0.5 mM Mg2e
( Fig. 2A ). The same strain tested in the same assay medium was more resistant to killing by gentamicin when grown before the killing assay in Mg2-deficient medium. Strains H181 and H185 were quite resistant regardless of growth conditions, although their resistance could be augmented by growth in the Mg2+-deficient medium. Comparable results were obtained with streptomycin ( Fig. 2B) (Fig. 2) .
Streptomycin uptake in susceptible and resistant strains. The pattern of streptomycin uptake in both strains H103 and H181 (illustrated by a typical experiment in Fig. 3 ) followed three-phase kinetics, as described by Bryan The major alteration in the kinetics of streptomycin uptake seen in the resistant strain, H181, was that at all concentrations of antibiotic used transition from the early slow phase of uptake (EDP-I) to the later rapid phase (EDP-II) was delayed in the resistant strain (Fig. 4) . This difference was consistently observed in seven separate experiments, each using several levels of antibiotic.
Permeabilization of the outer membrane by aminoglycosides. The ability of aminoglycosides and Tris-hydrochloride to alter outer membrane permeability was investigated by exainiing the effect of these agents in promoting lysis by lysozyme ( Fig. 5 and 6 ). Lysozyme is normally unable to penetrate the outer membrane of gram-negative bacteria to reach its site of activity, the peptidoglycan. As a control, we confirmed that lysozyme alone did not cause lysis of our strains. Treatment with gentamicin alone resulted in a slow decrease in OD6oo, but only after a prolonged delay (Fig. 5A) . The combination of lysozyme and gentamicin however, led to very rapid cell lysis. At high levels of gentamicin (10 to 25 ,ug/ml), there was a 90% drop in absorbance within 1 min.
Conditions which are known to block transport of aminoglycosides (5, 24) did not interfere with the permeabilization of the outer membrane to lysozyme (Fig. 5) . Lysis by gentamicin and lysozyme was very similar in the presence or absence of cyanide, which is known to inhibit aminoglycoside uptake, probably at the level of the cytoplasmic membrane. In contrast, the lysis mediated by gentamicin in the absence of lysozyme was 100% inhibited by cyanide (Fig. 5A) .
The uncouplers dinitrophenol and sodium azide also had no effect on gentamicin-lysozyme lysis (data not shown), indicating that the process did not require an energized membrane. Chloramphenicol, which is known to prevent aminoglycoside killing (13, 14, 24) and eliminate the late rapid phase of aminoglycoside uptake (5), also failed to inhibit lysis by gentamicin and lysozyme (Fig. 5B) with lysozyme caused some lysis, but at a relatively low rate and after a slight delay. However, it clearly did not interfere with the rapid gentamicin-promoted lysozyme lysis. Ribosomally altered strA mutants are resistant to very high levels of streptomycin and do not show the late rapid uptake phase of streptomycin (4). Streptomycin-mediated lysozyme lysis was indistinguishable in the wild-type PA01 strain H103 and a strA mutant of PAO1 (data not shown).
As cyanide prevents aminoglycoside uptake (4, 5) but did not prevent its effect on outer membrane permeability, 1 mM KCN was used in subsequent experiments. Figure 6 shows the lytic activity of aminoglycosides and Tris in the presence of cyanide. With gentamicin, lysis occurred very rapidly and the percentage of cells lysed was proportional to the amount of aminoglycoside added. The same effect could be obtained with streptomycin, but as in the killing experiment, much higher levels of this antibiotic were required. High concentrations of Tris (0.1 to 0.3 M) were also able to promote lysis by lysozyme, although Tris-lysozyme lysis was relatively slow. We also tried high levels of the polyamines spermine tetrahydrochloride (300 ,ug/ml) or spermidine trihydrochloride (500 Ag/ ml) with lysozyme. These combinations did not result in lysis. We were unable to obtain promotion of lysozyme lysis with streptomycin bound to agarose beads through a 1-nm spacer, although such could also be demonstrated for cells resuspended in 10 mM Tris-hydrochloride, pH 7.4, or 10 mM HEPES (N'-2-hydroxyethylpiperazine-2-ethanesulfonic acid) buffer, pH 7.2, in the absence of a carbon source. This amount of Tris-hydrochloride was insufficient to promote lysozyme lysis in the absence of aminoglycoside (Fig. 6C   and 7 ). The addition of 1 mM Mg2e to such cells completely inhibited gentamicin-mediated lysozyme lysis of cells (Fig. 7) levels. In both mutants and wild type, high levels of protein Hi were associated with increased resistance to killing and lysis by polymyxin and EDTA (21) . We have now shown that protein Hi-overproducing cells are also relatively resistant to killing by aminoglycosides ( Fig. 1 and 2 ). Our previous data (21) (23) have demonstrated that polymyxin has a higher affinity for Salmonella typhimurium lipopolysaccharide than does Mg2+, whereas others have demonstrated that moderately high levels of Mg2e are necessary to inhibit polymyxin activity (6) . In the case of aminoglycosides, antagonism by Mg2e occurs at quite low Mg2e levels, and this competition tends to mask the protective effects of protein Hi when the protein is iriduced by growth in low Mg2". Thus, in minimal inhibitory concentration measurements of aminoglycoside susceptibility, P. aeruginosa cells in low Mg2e are apparently more susceptible than cells in high Mg2e. When the differential competitive effects of Mg2e are eliminated by comparison of loss of viability in a common assay medium ( Fig.   1 and 2 ), cells grown in Mg2e-deficient medium are actually more resistant to aminoglycoside killing than cells grown in Mg2+-sufficient medium.
Aminoglycoside uptake in both Escherichia coli and P. aeruginosa has been shown to occur in three consecutive phases (4,.5): an initial rapid electrostatic binding, followed by an early slow uptake phase (EDP-I) and a later rapid uptake phase (EDP-II). The binding is energy independent, whereas the two latter phases are energy requiring and occur only in presence of an energized cytoplasmic membrane and electron transport (4, 5) . EDP-ll may coincide with or follow the onset of loss of viability, since both EDP-II and lethality can be inhibited with chloramphenicol (4, 13) and do not occur in ribosomally resistant (strA) strains (4). Alteration of ribosomal affinity in other mutants also affects uptake (1) . Comparison of streptomycin uptake in wild-type strains with uptake in resistant mutants which overproduce protein Hi showed that in the resistant strains the late rapid phase EDP-ll was always delayed (Fig. 3  and 4) . It would thus appear that the outer membrane has a critical influence on the events required to initiate EDP-II. Somewhat similar delays in the onset of EDP-ll have been observed for certain E. coli mutants with altered ribosomal affinity to aminoglycosides (1 (3), the hydrophilic pathway of antibiotic uptake may offer an alternative, efficient means of streptomycin permeation (9) .
Streptomycin action in such organisms should be, and is, less affected by Mg2e antagonism (18) .
An alternative explanation for our results might be that protein Hi is a magnesium-binding outer membrane protein which also binds gentamicin and streptomycin and thus specifically limits access of aminoglycosides to porin. However, as described in Results, we could demonstrate no signficant differences in the binding of streptomycin to our mutant strain H181 with high protein Hi levels when compared with our wild-type strain H103. In addition, at a streptomycin concentration with which we could demonstrate a large difference in killing of strains H181 and H103 (Fig. 2B) The ability of aminoglycosides to interact with the outer membrane and promote a significant alteration in its permeability was shown by both cell lysis in the presence of lysozyme and aminoglycosides and increased hydrolysis of nitrocefin in the presence of gentamicin. Lysozyme is normally inactive on gram-negative bacteria as it is unable to penetrate the outer membrane to reach its site of activity, the peptidoglycan. Previous studies have demonstrated that either polymyxin or EDTA can permeabilize the outer membrane to lysozyme (3, 15, 16) . In this study we have shown that gentamicin, streptomycin, and, to a lesser extent, Tris-hydrochloride overcame this penetration barrier, allowing lysozyme to attack the peptidoglycan and lyse the cells.
Lysozyme itself is known to bind to outer membranes (7) , and this ability may contribute to the efficiency of its permeation in aminoglycosidetreated cells. This is further suggested by the relatively inefficient gentamicin-mediated permeabilization of outer membranes to nitrocefin, a chromogenic f,-lactam. In fact, this implies that aminoglycoside-mediated permeabilization has some specificity for cationic substrates such as lysozyme and aminoglycosides (see below).
The permeabilization we observe cannot be attributed to aminoglycoside killing as we have shown that it occurs under conditions in which aminoglycosides are known not to be transported or lethal (5, 14) , such as in chloramphenicol-or KCN-treated cells, and can occur even in ribosomally resistant strA strains. This differentiates the effects we describe from the extreme outer membrane disruptions in aminoglycosidetreated cells, as has been seen in electron microscope studies (15) . Such disruptions occur only under conditions resulting in cell death.
Aminoglycosides are clearly able to promote the passage of other molecules through the outer membrane, and it seems likely that they are also capable of promoting their own transport. We have observed that the amounts of gentamicin and streptomycin required to cause permeabilization of outer membranes to lysozyme (Fig. 6) are 10-to 20-fold higher than the concentrations resulting in rapid cell killing (Fig. 2) . This may be explained by the different sizes of the molecules involved, since killing would involve permeabilization to the aminoglycosides themselves, which are molecules of 500 to 600 daltons, whereas aminoglycoside-promoted lysozyme lysis would involve permeabilization to lysozyme, a protein of 14,000 daltons. In the latter case, a more extreme disruption of the outer membrane would be required. We propose that aminoglycoside uptake and killing requires interaction with an Mg2" binding site at the outer membrane. This interaction promotes uptake of the antibiotic into the periplasm, permitting further transport at the level of the cytoplasmic membrane. We observed that Mg2+ was able to completely inhibit aminoglycoside-mediated permeabilization to lysozyme. This inhibition, coupled with the results of killing experiments with protein Hi-overproducing strains, strongly suggests that the site of aminoglycoside activity at the outer membrane is an Mg2e binding site.
Competition at the level of the outer membrane may well explain the unusually high antagonism of aminoglycosides by divalent cations (18, 25) in P. aeruginosa, although it is probable that other sites of competition also exist. Our results also suggest that the ability of a~ninoglycosides to promote ptrmeabilization of the outer membrane may in fact be a major determinant in their activity. We have shown that gentamicin is more active than streptomycin in inducing permeability to lysozyme. This difference is closely reflected by their relative effectiveness as measured in killing assays or minimal inhibitory concentration determinations. In this light, it is interesting that some of the new antipseudomonal aminoglycosides differ from their parent compounds largely in their efficiency of transport (17) rather than in their inhibition of ribosomal function. Improved ability to interact with the outer membrane could, in part, account for their increased transport.
